Strattera® is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). The efficacy of Strattera Capsules was established in seven clinical trials in outpatients with ADHD.
Medications Commonly Used to Treat ADHD, Page 3

Photo by Arenamontanus - http://flic.kr/p/5HYVet
ADHD is commonly treated with stimulants requiring close supervision by a doctor and/or parents. One non-stimulant ADHD medication, Strattera, has been shown to be associated with suicidal thoughts in children and teenagers with ADHD.
Strattera
Vyvanse
Vyvanse, a prodrug of the CNS stimulant dextroamphetamine, is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Vyvanse is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome.
